R3HCC1L
gene geneOn this page
Also known as GIDRP88PSORT
Summary
R3HCC1L (R3H domain and coiled-coil containing 1 like, HGNC:23512) is a protein-coding gene on chromosome 10q24.2, encoding Coiled-coil domain-containing protein R3HCC1L (Q7Z5L2).
Located in exon-exon junction complex.
Source: NCBI Gene 27291 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 154 total
- MANE Select transcript:
NM_001351015
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23512 |
| Approved symbol | R3HCC1L |
| Name | R3H domain and coiled-coil containing 1 like |
| Location | 10q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GIDRP88, PSORT |
| Ensembl gene | ENSG00000166024 |
| Ensembl biotype | protein_coding |
| Entrez | 27291 |
Gene structure
Transcript identifiers
Ensembl transcripts: 42 — 42 protein_coding
ENST00000298999, ENST00000314594, ENST00000370584, ENST00000370586, ENST00000612478, ENST00000613938, ENST00000903208, ENST00000903209, ENST00000903210, ENST00000903211, ENST00000903212, ENST00000903213, ENST00000903214, ENST00000903215, ENST00000903216, ENST00000903217, ENST00000903218, ENST00000903219, ENST00000903220, ENST00000903221, ENST00000903222, ENST00000903223, ENST00000903224, ENST00000903225, ENST00000903226, ENST00000903227, ENST00000924825, ENST00000924826, ENST00000924827, ENST00000924828, ENST00000924829, ENST00000924830, ENST00000924831, ENST00000963058, ENST00000963059, ENST00000963060, ENST00000963061, ENST00000963062, ENST00000963063, ENST00000963064, ENST00000963065, ENST00000963066
RefSeq mRNA: 13 — MANE Select: NM_001351015
NM_001256619, NM_001256620, NM_001256621, NM_001351010, NM_001351011, NM_001351012, NM_001351013, NM_001351014, NM_001351015, NM_001351016, NM_001351017, NM_014472, NM_138469
CCDS: CCDS31267, CCDS58093, CCDS73178
Canonical transcript exons
ENST00000298999 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001099059 | 98236024 | 98236164 |
| ENSE00001099060 | 98234446 | 98234516 |
| ENSE00001099061 | 98235425 | 98235520 |
| ENSE00001099063 | 98231512 | 98231687 |
| ENSE00001453088 | 98244091 | 98244897 |
| ENSE00001453092 | 98156093 | 98156147 |
| ENSE00001453093 | 98134657 | 98134706 |
| ENSE00002497545 | 98162883 | 98162975 |
| ENSE00003537783 | 98163293 | 98163397 |
| ENSE00003728851 | 98208101 | 98209899 |
Expression profiles
Bgee: expression breadth ubiquitous, 197 present calls, max score 93.29.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.0808 / max 162.6621, expressed in 1741 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106478 | 10.6925 | 1737 |
| 106477 | 0.3883 | 208 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.29 | gold quality |
| right testis | UBERON:0004534 | 89.98 | gold quality |
| left testis | UBERON:0004533 | 89.97 | gold quality |
| sperm | CL:0000019 | 89.10 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.50 | gold quality |
| testis | UBERON:0000473 | 88.18 | gold quality |
| granulocyte | CL:0000094 | 87.00 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.76 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.31 | gold quality |
| male germ cell | CL:0000015 | 85.75 | silver quality |
| calcaneal tendon | UBERON:0003701 | 85.48 | gold quality |
| skin of leg | UBERON:0001511 | 83.86 | gold quality |
| ventricular zone | UBERON:0003053 | 83.73 | gold quality |
| endocervix | UBERON:0000458 | 82.73 | gold quality |
| ectocervix | UBERON:0012249 | 82.69 | gold quality |
| transverse colon | UBERON:0001157 | 82.65 | gold quality |
| tibial nerve | UBERON:0001323 | 82.61 | gold quality |
| blood | UBERON:0000178 | 82.38 | gold quality |
| skin of abdomen | UBERON:0001416 | 82.37 | gold quality |
| cortical plate | UBERON:0005343 | 82.31 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 82.02 | gold quality |
| minor salivary gland | UBERON:0001830 | 81.91 | gold quality |
| esophagus mucosa | UBERON:0002469 | 81.89 | gold quality |
| spleen | UBERON:0002106 | 81.80 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 81.76 | gold quality |
| popliteal artery | UBERON:0002250 | 81.70 | gold quality |
| tibial artery | UBERON:0007610 | 81.70 | gold quality |
| right lung | UBERON:0002167 | 81.62 | gold quality |
| rectum | UBERON:0001052 | 81.53 | gold quality |
| monocyte | CL:0000576 | 81.50 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting R3HCC1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-2116-3P | 99.74 | 64.32 | 889 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-217-5P | 99.49 | 69.93 | 1419 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-20A-3P | 99.44 | 69.10 | 1575 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-4480 | 99.42 | 66.02 | 735 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-6807-3P | 99.15 | 69.23 | 1275 |
| HSA-MIR-6814-5P | 99.03 | 66.68 | 1273 |
| HSA-MIR-5001-3P | 98.91 | 67.28 | 1394 |
| HSA-MIR-26B-3P | 98.71 | 67.49 | 1102 |
| HSA-MIR-6868-3P | 98.63 | 69.64 | 2259 |
| HSA-MIR-299-5P | 98.56 | 71.14 | 1140 |
| HSA-MIR-188-5P | 97.89 | 67.01 | 756 |
| HSA-MIR-4294 | 97.86 | 65.72 | 1110 |
| HSA-MIR-3198 | 97.84 | 65.64 | 579 |
| HSA-MIR-4309 | 97.84 | 65.45 | 588 |
| HSA-MIR-6866-3P | 97.38 | 66.94 | 748 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | r3hcc1l | ENSDARG00000089243 |
| mus_musculus | R3hcc1l | ENSMUSG00000025184 |
| rattus_norvegicus | R3hcc1l | ENSRNOG00000051256 |
| drosophila_melanogaster | CG2162 | FBGN0035388 |
| caenorhabditis_elegans | WBGENE00008622 |
Paralogs (1): R3HCC1 (ENSG00000104679)
Protein
Protein identifiers
Coiled-coil domain-containing protein R3HCC1L — Q7Z5L2 (reviewed: Q7Z5L2)
Alternative names: Growth inhibition and differentiation-related protein 88, Putative mitochondrial space protein 32.1, R3H and coiled-coil domain-containing protein 1-like
All UniProt accessions (2): A0A384DVK4, Q7Z5L2
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. May interact with the exon junction complex (EJC) composed at least of CASC3, EIF4A3, MAGOH and RBM8A.
Tissue specificity. Expressed in placenta.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z5L2-1 | 1 | yes |
| Q7Z5L2-2 | 2 | |
| Q7Z5L2-3 | 3 |
RefSeq proteins (13): NP_001243548, NP_001243549, NP_001243550, NP_001337939, NP_001337940, NP_001337941, NP_001337942, NP_001337943, NP_001337944, NP_001337945, NP_001337946, NP_055287, NP_612478 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR039884 | R3HC1/R3HCL | Family |
UniProt features (21 total): sequence variant 7, region of interest 4, splice variant 3, sequence conflict 2, modified residue 2, chain 1, mutagenesis site 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z5L2-F1 | 51.36 | 0.11 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 688, 712
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 14–20 | loss of interaction with the ejc. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GTTAAAG_MIR302B, DARWICHE_PAPILLOMA_PROGRESSION_RISK, MORF_RAD51L3, ATGTTAA_MIR302C, MORF_PRKCA, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, ELK1_01, MORF_ATF2, MORF_BCL2L11, MYB_Q5_01, GOCC_EXON_EXON_JUNCTION_COMPLEX, SCGGAAGY_ELK1_02, MORF_IL16, MORF_DMPK
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): exon-exon junction complex (GO:0035145)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| nuclear protein-containing complex | 1 |
Protein interactions and networks
STRING
594 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| R3HCC1L | P0DN79 | P0DN79 | 844 |
| R3HCC1L | H7C2H4 | H7C2H4 | 844 |
| R3HCC1L | TBL1X | O60907 | 609 |
| R3HCC1L | PDX1 | P52945 | 448 |
| R3HCC1L | PHGDH | O43175 | 434 |
| R3HCC1L | TMEM89 | A2RUT3 | 336 |
| R3HCC1L | CEP55 | Q53EZ4 | 330 |
| R3HCC1L | SLC36A4 | Q6YBV0 | 322 |
| R3HCC1L | HSPD1 | P10809 | 322 |
| R3HCC1L | PALM3 | A6NDB9 | 317 |
| R3HCC1L | HEMK1 | Q9Y5R4 | 307 |
| R3HCC1L | BBX | Q8WY36 | 297 |
| R3HCC1L | PSAT1 | Q9Y617 | 275 |
| R3HCC1L | HSPE1 | P61604 | 270 |
| R3HCC1L | ZBTB25 | P24278 | 268 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| R3HCC1L | DNAAF19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAAF19 | R3HCC1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| R3HCC1L | EEF1G | psi-mi:“MI:0915”(physical association) | 0.400 |
| EGLN3 | FAM168B | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CDKN3 | CST8 | psi-mi:“MI:0914”(association) | 0.350 |
| SARS1 | R3HCC1L | psi-mi:“MI:0914”(association) | 0.350 |
| CEP19 | NUDT19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| MKS1 | GARRE1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| POC1A | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| EZR | EEF2K | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (29): CCDC103 (Two-hybrid), R3HCC1L (Affinity Capture-RNA), PABPC1 (Affinity Capture-Western), MAGOH (Affinity Capture-Western), RBM8A (Affinity Capture-Western), R3HCC1L (Affinity Capture-MS), R3HCC1L (Affinity Capture-MS), R3HCC1L (Proximity Label-MS), R3HCC1L (Proximity Label-MS), R3HCC1L (Proximity Label-MS), R3HCC1L (Affinity Capture-MS), R3HCC1L (Affinity Capture-MS), R3HCC1L (Affinity Capture-MS), R3HCC1L (Affinity Capture-MS), R3HCC1L (Proximity Label-MS)
ESM2 similar proteins: A0JM80, A6H8Y1, A7MBJ2, D3ZF42, E9Q6J5, F4I700, F4J3S1, F4KCE9, F6QRE9, O04251, O82345, P23497, P46100, P48785, P48786, Q04996, Q05B65, Q0WTB8, Q13342, Q15361, Q32MZ4, Q3UZ39, Q3ZBR9, Q4QSC8, Q571C7, Q5H9K5, Q5RHP9, Q61687, Q66HF9, Q7YQM3, Q7YQM4, Q7Z5L2, Q8BJM3, Q8C4A5, Q8C9B9, Q8GZ87, Q8H991, Q8IW19, Q92576, Q940Y3
Diamond homologs: Q7Z5L2, Q8BJM3, Q8BSI6, Q9Y3T6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
154 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 129 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2147 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:98209896:AGAGG:A | donor_loss | 1.0000 |
| 10:98209897:GAG:G | donor_gain | 1.0000 |
| 10:98209899:GGT:G | donor_loss | 1.0000 |
| 10:98209900:G:T | donor_loss | 1.0000 |
| 10:98209901:T:A | donor_loss | 1.0000 |
| 10:98231510:A:AG | acceptor_gain | 1.0000 |
| 10:98231511:G:GG | acceptor_gain | 1.0000 |
| 10:98231511:GTT:G | acceptor_gain | 1.0000 |
| 10:98231511:GTTA:G | acceptor_gain | 1.0000 |
| 10:98231511:GTTAT:G | acceptor_gain | 1.0000 |
| 10:98231683:TATCA:T | donor_gain | 1.0000 |
| 10:98231684:ATCA:A | donor_gain | 1.0000 |
| 10:98231685:TCA:T | donor_gain | 1.0000 |
| 10:98231685:TCAG:T | donor_loss | 1.0000 |
| 10:98231686:CA:C | donor_gain | 1.0000 |
| 10:98231687:AGT:A | donor_loss | 1.0000 |
| 10:98231688:GTGA:G | donor_gain | 1.0000 |
| 10:98231689:T:A | donor_loss | 1.0000 |
| 10:98231691:AGTA:A | donor_loss | 1.0000 |
| 10:98231692:G:GG | donor_gain | 1.0000 |
| 10:98234444:A:AG | acceptor_gain | 1.0000 |
| 10:98234445:G:GA | acceptor_gain | 1.0000 |
| 10:98234445:GA:G | acceptor_gain | 1.0000 |
| 10:98234445:GAAA:G | acceptor_gain | 1.0000 |
| 10:98234512:TACAG:T | donor_loss | 1.0000 |
| 10:98234513:ACAGG:A | donor_loss | 1.0000 |
| 10:98234514:CAGG:C | donor_loss | 1.0000 |
| 10:98234515:AG:A | donor_loss | 1.0000 |
| 10:98234516:GGT:G | donor_loss | 1.0000 |
| 10:98234517:G:A | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000001213 (10:98193440 A>G), RS1000003852 (10:98173885 G>A), RS1000076583 (10:98145191 G>A,T), RS1000092823 (10:98207182 C>G), RS1000104993 (10:98174551 A>G), RS1000131768 (10:98157683 C>CT), RS1000153292 (10:98217707 T>C), RS1000163322 (10:98229507 A>G), RS1000203279 (10:98163646 C>T), RS1000235123 (10:98243161 T>C), RS1000265987 (10:98205820 A>C,G), RS1000279444 (10:98167669 A>G), RS1000283156 (10:98239786 G>A), RS1000301865 (10:98190751 C>T), RS1000313832 (10:98192750 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002740_37 | Inflammatory skin disease | 7.000000e-06 |
| GCST008129_21 | Body mass index | 8.000000e-16 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bufotalin | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| MT19c compound | increases expression | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Thiram | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_1870 | MEC-1 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): atopic eczema